RxDoctor Payments Data

Lorena Chicas, PA

Physician Assistant · Linden, NJNPI 1255634093

Payments from drug & device makers

$2,328in general payments, 2019–2025

Across 127 payments — averaging $18.33 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$888
  • AstraZeneca$373
  • Pfizer$225
  • Amgen$212
  • GSK$166
  • Abbott$130
  • plus $333 from 7 others

What the payments were for

  • Food & beverage$2,328100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Novo Nordisk59$888
AstraZeneca12$373
Pfizer13$225
Amgen10$212
GSK10$166
Abbott6$130
Lilly USA, LLC5$96
Exact Sciences3$77
Genentech USA, Inc.4$59
Merck2$46
Astellas Pharma US Inc1$23
Phadia US Inc.1$18
VBI Vaccine (delaware) Inc.1$14

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,328 in reported general payments places this provider in the 85th percentile of 2,726 physician assistant providers in New Jersey.

See all physician assistant providers in New Jersey

Medicare billing

Part B allowed, 2024
$58,928
Medicare patients
172
Services billed
1,952

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
JardianceEmpagliflozin11$15,894
Valsartan-HydrochlorothiazideValsartan/Hydrochlorothiazide20$1,213
Valsartan46$983
Atorvastatin Calcium108$785
Amlodipine Besylate117$604
Rosuvastatin Calcium51$384
Losartan Potassium74$360
Metformin Hcl74$354
Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst17$259
Mometasone Furoate14$254
Losartan-HydrochlorothiazideLosartan/Hydrochlorothiazide15$221
Metoprolol Succinate22$208
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav30$204
Levothyroxine Sodium28$199
Mupirocin18$161

Paid to pharmacies, not to this prescriber.

Other physician assistant in Linden

See the full list for New Jersey

Where these figures come from

Is this you, or does something look wrong? →